More profoundly, the presence of CHIP, particularly CLL-related CHIP, significantly amplified the risk of incident lymphoid malignancy among individuals with MBL, whereas CHIP alone may be insufficient to drive progression to lymphoid malignancy. This evidence concerns the gene STUB1 and B-cell chronic lymphocytic leukemia.